PharmaVOICE - 
May 2007
Purchase Issue

In Every Issue
E-Media
New Electronic and Web-based Applications, Sites, and Technologies CIS Launches [...]
By
For Art’s Sake
Each month, this department pays homage to memorable advertising and [...]
By
PharmaOutlet
Developing E-Processes for Patient Recruitment In the past decade, clinical-study [...]
By

Joan Bachenheimer

PharmaTrax
Agencies Ahead of Pharmaceutical Manufacturers in Online Research Despite increased [...]
By
On the Calendar
On the Calendar May 2007 Your Source for Life-Sciences Events [...]
By
What’s New
New Healthcare-related Products, Services, and Companies New Healthcare Marketing and [...]
By
Talent Pool
Pharma POOL Warwick S. Bedwell Roche Appoints VP and Global [...]
By
Raise Your Voice — Letters
Connecting the Dots: The Big Picture in Connected Health While [...]
By
UpFront
Consumer-Driven Healthcare Retail Primary Care One in 10 retail clinic [...]
By
Letter from the Editor
If you are feeling downtrodden by the continuing barrage of [...]
By

Taren Grom, Editor

On The Cover

Going Public: Pharma’s Commitment to Public Health
By Elisabeth Pena Villarroel Forum The pharmaceutical industry’s commitment to public health is at the core of its very existence; the mission and work of the industry’s companies are to create, develop, and bring to market lifesaving and life-enhancing medicines. A natural extension of this mission is the industry’s participation and sponsorship of myriad public-health [...]
By

Elisabeth Pena Villarroel

Features

Managed Markets: Employers
The degree of skill needed to negotiate in the pharmacy benefit waters, especially for larger employers, is increasing. Experts say pharmaceutical companies must have a strategy to address employer needs. By Denise Myshko Employers: A Growing Influence While most employers are focused on managing healthcare costs and look to their benefit plans to do that, [...]
By

Denise Myshko

One Step Ahead — Dr. Mitchell S. Steiner
Bio An apt descriptor for Mitchell S. Steiner, M.D., F.A.C.S., is a man ahead of his time. This character trait has helped him in his academic background, in helping patients, and in establishing a biopharmaceutical company focused on novel hormonal therapeutics for cancer, muscle wasting, osteoporosis, bone loss, as well as other serious conditions. From [...]
By

Kim Ribbink

Sales Training: Moving Beyond the Message
By Taren Grom With the ongoing transformations in pharmaceutical salesforces, it’s become vitally important for sales representatives to provide value beyond the marketing message. Pfizer, Wyeth, AstraZeneca, and many other major pharmaceutical companies are taking feet off the street. This reversal in the long-held “arms race” strategy has analysts and physicians nodding in agreement that [...]
By

Taren Grom, Editor

Section 199 Deduction for Qualified Production Activity Income
In October of 2004, the U.S. Congress and President Bush signed into law the American Jobs Creation Act of 2004. The Act is the first major corporate tax act in over a decade. A key provision of the Act is a new domestic manufacturing deduction designed to improve the global competitiveness of U.S. multinationals, known [...]
By
A Constellation of Talent
By Taren Grom, Editor A salute to this year’s Healthcare Businesswomen’s Association Rising Stars. The HBA Rising Star Class of 2007 is personified by 81 outstanding women who demonstrate clear leadership abilities, have an appreciation for mentors and role models, and who are not afraid to chart a course for success for those who follow [...]
By

Taren Grom, Editor

Nanotech Comes of Age
By Kim Ribbink The once futuristic science of nanotechnology has come of age and branched into a broad spectrum of applications. Among these is nanomedicine: medicinal intervention at the molecular level for curing disease, repairing damaged tissue, and monitoring biological systems. The National Institutes of Health defines nanotechnology as the creation and use of materials [...]
By

Kim Ribbink

FEEDBACK